290 related articles for article (PubMed ID: 23719512)
1. Modification of amyloid-β1-42 fibril structure by methionine-35 oxidation.
Hou L; Lee HG; Han F; Tedesco JM; Perry G; Smith MA; Zagorski MG
J Alzheimers Dis; 2013; 37(1):9-18. PubMed ID: 23719512
[TBL] [Abstract][Full Text] [Related]
2. Simulations of monomeric amyloid β-peptide (1-40) with varying solution conditions and oxidation state of Met35: implications for aggregation.
Brown AM; Lemkul JA; Schaum N; Bevan DR
Arch Biochem Biophys; 2014 Mar; 545():44-52. PubMed ID: 24418316
[TBL] [Abstract][Full Text] [Related]
3. Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation.
Hou L; Shao H; Zhang Y; Li H; Menon NK; Neuhaus EB; Brewer JM; Byeon IJ; Ray DG; Vitek MP; Iwashita T; Makula RA; Przybyla AB; Zagorski MG
J Am Chem Soc; 2004 Feb; 126(7):1992-2005. PubMed ID: 14971932
[TBL] [Abstract][Full Text] [Related]
4. Methionine 35 oxidation reduces fibril assembly of the amyloid abeta-(1-42) peptide of Alzheimer's disease.
Hou L; Kang I; Marchant RE; Zagorski MG
J Biol Chem; 2002 Oct; 277(43):40173-6. PubMed ID: 12198111
[TBL] [Abstract][Full Text] [Related]
5. Methionine 35 oxidation reduces toxic effects of the amyloid beta-protein fragment (31-35) on human red blood cell.
Clementi ME; Martorana GE; Pezzotti M; Giardina B; Misiti F
Int J Biochem Cell Biol; 2004 Oct; 36(10):2066-76. PubMed ID: 15203119
[TBL] [Abstract][Full Text] [Related]
6. Electrochemistry of Alzheimer Disease Amyloid Beta Peptides.
Chiorcea-Paquim AM; Enache TA; Oliveira-Brett AM
Curr Med Chem; 2018; 25(33):4066-4083. PubMed ID: 29446720
[TBL] [Abstract][Full Text] [Related]
7. Oxidation of methionine 35 reduces toxicity of the amyloid beta-peptide(1-42) in neuroblastoma cells (IMR-32) via enzyme methionine sulfoxide reductase A expression and function.
Misiti F; Clementi ME; Giardina B
Neurochem Int; 2010 Mar; 56(4):597-602. PubMed ID: 20060866
[TBL] [Abstract][Full Text] [Related]
8. Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid beta-peptide 1-42.
Butterfield DA; Kanski J
Peptides; 2002 Jul; 23(7):1299-309. PubMed ID: 12128086
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's amyloid beta-peptide (1-42): involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide.
Butterfield DA; Bush AI
Neurobiol Aging; 2004; 25(5):563-8. PubMed ID: 15172731
[TBL] [Abstract][Full Text] [Related]
10. Methionine does not reduce Cu(II)-beta-amyloid!--rectification of the roles of methionine-35 and reducing agents in metal-centered oxidation chemistry of Cu(II)-beta-amyloid.
da Silva GF; Lykourinou V; Angerhofer A; Ming LJ
Biochim Biophys Acta; 2009 Jan; 1792(1):49-55. PubMed ID: 19061952
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
12. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
Tamaoka A
Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
[TBL] [Abstract][Full Text] [Related]
13. alphaB-crystallin competes with Alzheimer's disease beta-amyloid peptide for peptide-peptide interactions and induces oxidation of Abeta-Met35.
Narayanan S; Kamps B; Boelens WC; Reif B
FEBS Lett; 2006 Oct; 580(25):5941-6. PubMed ID: 17046756
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen bonding involving side chain exchangeable groups stabilizes amyloid quarternary structure.
Agarwal V; Linser R; Dasari M; Fink U; del Amo JM; Reif B
Phys Chem Chem Phys; 2013 Aug; 15(30):12551-7. PubMed ID: 23719770
[TBL] [Abstract][Full Text] [Related]
15. Attenuated amyloid-beta aggregation and neurotoxicity owing to methionine oxidation.
Johansson AS; Bergquist J; Volbracht C; Päiviö A; Leist M; Lannfelt L; Westlind-Danielsson A
Neuroreport; 2007 Apr; 18(6):559-63. PubMed ID: 17413657
[TBL] [Abstract][Full Text] [Related]
16. Lipid oxidation and modification of amyloid-β (Aβ) in vitro and in vivo.
Ellis G; Fang E; Maheshwari M; Roltsch E; Holcomb L; Zimmer D; Martinez D; Murray IV
J Alzheimers Dis; 2010; 22(2):593-607. PubMed ID: 20847409
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
[TBL] [Abstract][Full Text] [Related]
18. Role of phenylalanine 20 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity.
Boyd-Kimball D; Mohmmad Abdul H; Reed T; Sultana R; Butterfield DA
Chem Res Toxicol; 2004 Dec; 17(12):1743-9. PubMed ID: 15606152
[TBL] [Abstract][Full Text] [Related]
19. Methionine 35 oxidation reduces toxic and pro-apoptotic effects of the amyloid beta-protein fragment (31-35) on isolated brain mitochondria.
Misiti F; Martorana GE; Nocca G; Di Stasio E; Giardina B; Clementi ME
Neuroscience; 2004; 126(2):297-303. PubMed ID: 15207347
[TBL] [Abstract][Full Text] [Related]
20. Rodent Abeta(1-42) exhibits oxidative stress properties similar to those of human Abeta(1-42): Implications for proposed mechanisms of toxicity.
Boyd-Kimball D; Sultana R; Mohmmad-Abdul H; Butterfield DA
J Alzheimers Dis; 2004 Oct; 6(5):515-25. PubMed ID: 15505374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
